US FDA Launches OTC Monographs Online Portal
Executive Summary
OTC Monographs@FDA is a publicly accessible repository for proposed, final, and interim final orders for OTC monograph drugs via the new OTC drug review program created by last year’s CARES Act. So far, the agency has posted seven of 32 “deemed” final orders created by the legislation.
You may also be interested in...
US FDA Meets Initial Deadlines In OTC Monograph Overhaul While It's Rebuilding The Program
Authorization was a long time coming for FDA to reform OTC monograph program and streamline process to change formulations, indications or labeling for large majority of drugs available nonprescription. As program is overhauled, monograph updates may seem to be coming just as slowly.
FDA’s Proposed Order For Sunscreens, A First Under OTC Reforms, Reprises 2019 Proposed Rule
As anticipated, the US FDA’s proposed order for sunscreens released on 24 September creates a bridge to the agency’s 2019 proposed rule before the CARES Act overhauled OTC drug review in March 2020.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.